Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regrelor in CABG surgery
NCT00316212Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Apr 2006
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of regrelor in coronary artery disease (CAD), sponsored by Merck & Co.. Started Apr 2006; status: terminated.
02
Drugs
regrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00316212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00316212.